• 期刊简介

Hematology Reports (ISSN 2038-8330) 是一个国际化、经同行评审的开放获取期刊。期刊主要发表血液学及相关领域的原创研究、综述、病例报告等文章，研究方向涵盖血液系统疾病的预防、诊断与治疗，以及相关分子与细胞生物学、遗传学、病理生理学、流行病学和临床研究等。期刊致力于为科研工作者提供高效、可靠的学术交流平台，促进血液学领域前沿研究成果的传播。目前期刊已被ESCI、Scopus、PubMed、DOAJ等多个重要数据库收录，最新Impact Factor为1.2，CiteScore为2.3。

期刊scope

血友病；特发性血小板减少性紫癜；淋巴瘤；白血病；骨髓瘤；骨髓增生异常综合征；常见血液肿瘤；缺铁性贫血；再生障碍性贫血；地中海贫血；深静脉血栓形成；肺栓塞；免疫性血小板减少症；冯维勒布兰德病；血液系统恶性肿瘤；血红蛋白病；输血医学；骨髓移植；干细胞移植；诊断、治疗与护理；造血细胞；细胞生物学；遗传学；病理生理学；流行病学；对照试验研究

期刊主编

Prof. Dr. Claudio Cerchione Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Italy

• 精选文章

1. A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia

2024年Menin抑制剂更新：针对KMT2A重排及NPM1突变急性髓系白血病的新型靶向药物

Anna Candoni and Gabriele Coppola

https://www.mdpi.com/2756140

2. Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study

套细胞淋巴瘤患者生存结局：一项回顾性15年的真实世界研究

Emanuele Cencini et al.

https://www.mdpi.com/2642874

3. Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation

人工智能 (AI) 与药物诱导及特发性细胞减少症：AI在预防、预测及患者参与中的作用

Emmanuel Andrès et al.

https://www.mdpi.com/3291532

4. Association of Cognitive Impairment with Reduced Health-Related Quality of Life and Depression Among Survivors of Thrombotic Thrombocytopenic Purpura

血栓性血小板减少性紫癜 (TTP) 幸存者认知障碍与健康相关生活质量下降及抑郁的关联性研究

Sruthi Selvakumar et al.

https://www.mdpi.com/3519436

5. Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells

Exportin 1与Aurora激酶A抑制在多发性骨髓瘤细胞中的治疗潜力

Seiichi Okabe et al.

https://www.mdpi.com/3673700

• 特刊推荐

1. Next-Generation Hematology: Artificial Intelligence and Biomarker-Driven Innovations in Diagnosis and Therapy

下一代血液学：人工智能与基于生物标志物的诊断与治疗创新

Edited by Dr. Ioannis Tsamesidis and Dr. Ilias Pessach

Submission Deadline: 31 October 2026

https://www.mdpi.com/journal/hematolrep/special_issues/4S2J115G36

2. Recent Advances in the Diagnosis and Treatment of Relapsed and Refractory Lymphoid Malignancies

复发及难治性淋巴系统恶性肿瘤的诊断与治疗最新进展

Edited by Dr. John L. Vaughn and Dr. Marc J. Braunstein

Submission Deadline: 30 October 2026

https://www.mdpi.com/journal/hematolrep/special_issues/MIFRZSH400

3. Re-Defining Immune-Mediated Hematological Disorders: Mechanisms and Therapeutic Opportunities

免疫介导性血液疾病的重新定义：机制与治疗机遇

Edited by Dr. Roxane Darbousset and Dr. Julia Kuehn

Submission Deadline: 30 November 2026

https://www.mdpi.com/journal/hematolrep/special_issues/25419WR0QA

4. Myelodysplastic Syndromes: Recent Advances in Biology, Diagnosis, and Treatment

骨髓增生异常综合征：生物学、诊断与治疗的最新进展

Edited by Dr. Krzysztof Mądry, Prof. Dr. Ulrich Germing and Dr. Rafal Machowicz

Submission Deadline: 15 December 2026

https://www.mdpi.com/journal/hematolrep/special_issues/J422F757E7

5. Hemophilia: The Paradigm Shift and the Unresolved Challenges

血友病：范式转变与尚未解决的挑战

Edited by Dr. Felipe Querol

Submission Deadline: 30 September 2026

https://www.mdpi.com/si/260390

• 作者指南

如您对投稿有任何疑问，欢迎阅读作者指南，或联系 Hematology Reports 期刊编辑部 (hematolrep@mdpi.com)。

阅读作者指南：https://www.mdpi.com/journal/hematolrep/instructions

支持单位：